|
MechanismEGFR antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Anshi Pharmaceutical (Ningbo) Co., Ltd.
0 Patents (Medical) associated with Anshi Pharmaceutical (Ningbo) Co., Ltd.
100 Deals associated with Anshi Pharmaceutical (Ningbo) Co., Ltd.
100 Translational Medicine associated with Anshi Pharmaceutical (Ningbo) Co., Ltd.